In part 2 of this panel discussion, the panelists discuss the divide between investments being made by Pharma and CROs in new bioanalytical techniques and technologies.

Discussions include:

    Investments made by Pharma and CROs for new constructs
    Is there a real divide between CRO and Pharma?
    If so, why is this occurring?
    What are the gaps?
    What are the solutions?

In part 2 of this panel discussion, the panelists discuss the divide between investments being made by Pharma and CROs in new bioanalytical techniques and technologies. Discussions include: Investments made by Pharma and CROs for new constructs Is there a real divide between CRO and Pharma? If so, why is this occurring? What are the gaps? What are the solutions?

Share Bioanalysis Zone Roundtable Panel Discussion: Part 2 Pharma and CRO Investment

Sign up to save your podcasts

Bioanalysis Zone Roundtable Panel Discussion: Part 2 Pharma and CRO Investment

Bioanalysis Zone Roundtable Panel Discussion: Part 2 Pharma and CRO Investment